We created a propensity score to match GLP1-RA users and DDP4i users at a ratio of 1:1 using 120 characteristics selected a priori (listed in Table 1), Variables included: age, gender (self-reported), race and ethnicity (self-reported), demographics, personal history, vital signs, comorbidities, comorbidity and cardiovascular scores, frailty score, healthcare utilization, laboratory values, glucose-lowering medication classes, and other medication classes
HSDD the condition for which Vyleesi is FDA-approved is conceptualised as an imbalance toward excessive inhibition relative to excitation
On day 4, my first Ozempic nausea set in
If expression wanes over time which is possible can you re-treat
While some preclinical studies suggest certain probiotic strains, particularly those from the Lactobacillus and Bifidobacterium genera, might modulate gut hormone secretion, the evidence in humans remains limited and preliminary